Yes, Prima has had a rocky journey over the years and looking back at those announcements re earlier trials is a great reminder as to why so many people stuck with this treatment when things looked their grimist.
It is also food for thought re what can happen to a company low on cash or struggling for finance. Martin and the team have done an amazing job when it looked likely that cash would run out. With differing reports about the GFC and the current recovery, I like the fact Martin is still making sure money goes in the bank.
To think there was almost no Prima Biomed, look at the progress that has been made and the people who are now involved.
Regards and good luck
dc
provenge a 65/35 chance of approval, page-17
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.030(9.68%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 35.0¢ | 33.0¢ | $1.063M | 3.145M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 59718 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 128622 | 11 |
View Market Depth
| Last trade - 10.21am 14/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |